- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02151305
Different Hemostasis According to the Anesthetic Agents
May 27, 2014 updated by: Hyo-Seok Na, Seoul National University Bundang Hospital
The Influence of Propofol and Sevoflurane on Hemostasis During Ophthalmic Surgery: Rotational Thromboelastographic Study.
We investigated the hemostatic differences according to the main anesthetic agents by analyzing rotational thromboelastometry (ROTEM) under the hypothesis that propofol-based anesthesia would impair postoperative coagulability more than the sevoflurane-based anesthesia.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gyeonggi
-
Seongnam, Gyeonggi, Korea, Republic of, 463-707
- Seoul National University Bundang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patient scheduled for ophthalmic surgery under general anesthesia
- American Society of Anesthesiologist physical status I or II
Exclusion Criteria:
- hematologic disorder
- severe anemia
- liver disease
- kidney disease
- taking a medication interfering with hemostasis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Total intravenous anesthesia group
This group received propofol and remifentanil for the maintenance of general anesthesia.
|
|
Experimental: Inhalation anesthesia group
This group received sevoflurane for the maintenance of general anesthesia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Clotting time of ROTEM
Time Frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
Clot firmness time of ROTEM
Time Frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
Alpha angle of ROTEM
Time Frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
Maximum clot firmness of ROTEM
Time Frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Hemoglobin
Time Frame: 10 minutes before the induction of anesthesia
|
10 minutes before the induction of anesthesia
|
Hematocrit
Time Frame: 10 minutes before the induction of anesthesia
|
10 minutes before the induction of anesthesia
|
Platelet count
Time Frame: 10 minutes before the induction of anesthesia
|
10 minutes before the induction of anesthesia
|
International normalized ratio of prothrombin time
Time Frame: 10 minutes before the induction of anesthesia
|
10 minutes before the induction of anesthesia
|
Activated partial thromboplastin time
Time Frame: 10 minutes before the induction of anesthesia
|
10 minutes before the induction of anesthesia
|
Fibrinogen
Time Frame: 10 minutes before the induction of anesthesia
|
10 minutes before the induction of anesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
May 27, 2014
First Submitted That Met QC Criteria
May 27, 2014
First Posted (Estimate)
May 30, 2014
Study Record Updates
Last Update Posted (Estimate)
May 30, 2014
Last Update Submitted That Met QC Criteria
May 27, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Eye Diseases
- Retinal Diseases
- Lens Diseases
- Conjunctival Diseases
- Corneal Diseases
- Eye Hemorrhage
- Hemorrhage
- Cataract
- Keratitis
- Retinal Detachment
- Pterygium
- Vitreous Hemorrhage
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Platelet Aggregation Inhibitors
- Analgesics, Opioid
- Narcotics
- Hypnotics and Sedatives
- Anesthetics, Inhalation
- Remifentanil
- Propofol
- Sevoflurane
Other Study ID Numbers
- ROTEM_anesthesia
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitreous Hemorrhage
-
Panhandle Eye Group, LLPRecruitingDiabetic Vitreous HemorrhageMexico
-
Al Hadi HospitalCompletedDiabetic Vitreous HemorrhageKuwait
-
Kasr El Aini HospitalCompletedTractional Retinal Detachment | Diabetic Vitreous HemorrhageEgypt
-
Asan Medical CenterUnknownPost Vitrectomy State | Recurrent Diabetic Vitreous HemorrhageKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisRecruitingRetinal Detachment | Retinal Break | Spontaneous Vitreous HemorrhageFrance
-
University of Sao PauloUnknownHemorrhage | RecurrentBrazil
-
Aier School of Ophthalmology, Central South UniversityRecruitingVitreous Hemorrhage | Cataract | Rhegmatogenous Retinal Detachment | Epiretinal Membrane | Macular Disease | Vitreomacular Traction | Vitreous CloudyChina
-
University of Sao PauloUnknownVitreous Hemorrhage Secondary to PDRBrazil
-
Peregrine Eye and Laser InstituteAlcon ResearchRecruitingVitreous Hemorrhage | Retinal Detachment | Epiretinal Membrane | Vitrectomy | Macular Holes | Dislocated Intraocular Lens Into Vitreous | Retained Lens FragmentsPhilippines
-
The University of Hong KongAlcon ResearchCompletedVitreous Hemorrhage | Retinal Detachment | Epiretinal Membrane | Macula HoleHong Kong
Clinical Trials on Sevoflurane
-
Yeungnam University College of MedicineCompleted
-
University of RostockCompletedOther Specified Injuries of Vocal Cord, SequelaGermany
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminated
-
Kocaeli Derince Education and Research HospitalCompleted
-
Pontificia Universidad Catolica de ChileUnknown
-
Universiti Sains MalaysiaCompletedGeneral Anaesthesia | PaediatricsMalaysia
-
University Hospital, Clermont-FerrandCompleted
-
University Hospital, GhentCompleted
-
China International Neuroscience InstitutionCompletedGeneral Anesthesia | Urinary SurgeryChina